All In Biotech

Free tool

FAERS Monitor: Arthrotec

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020607 or its brand name (Arthrotec, Diclofenac Sodium, Misoprostol). Reports on generic versions are filed under their own applications.

Reports

6,640

Serious

5,019

76% of reports

Hospitalization

1,730

Death reported

306

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective1,203
  • pain900
  • arthralgia777
  • rheumatoid arthritis685
  • nausea634
  • fatigue557
  • drug hypersensitivity520
  • diarrhoea518
  • malaise450
  • headache414
  • dizziness411
  • pain in extremity384
  • joint swelling372
  • back pain359
  • dyspnoea331

Reports by year received

View as table
YearReports
2004191
2005282
2006249
2007247
2008205
2009231
2010381
2011290
2012416
2013340
2014276
2015371
2016401
2017366
2018443
2019498
2020615
2021248
2022222
2023131
2024128
202574
202635

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,519 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
rheumatoid arthritisSignal68519.217.911,807
joint swellingSignal3729.88.92,935
drug hypersensitivitySignal5208.57.93,473
arthralgiaSignal7775.95.53,237
back painSignal3594.94.41,121
painSignal9004.64.42,645
pain in extremitySignal3844.13.7920
malaiseSignal4503.33.0714
drug ineffectiveSignal1,2032.92.71,586
dizzinessSignal4112.62.4417
diarrhoeaSignal5182.52.3498
nauseaSignal6342.52.4612
fatigueSignal5572.32.1408
headacheSignal4142.11.9242
dyspnoea3311.91.7133

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.